位置:首页 > 蛋白库 > CED1_CAEEL
CED1_CAEEL
ID   CED1_CAEEL              Reviewed;        1111 AA.
AC   Q9XWD6; Q0E7J9; Q8T3A6; Q8T3A7;
DT   28-JUL-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   03-AUG-2022, entry version 150.
DE   RecName: Full=Cell death abnormality protein 1 {ECO:0000303|PubMed:11163239};
DE   Flags: Precursor;
GN   Name=ced-1 {ECO:0000303|PubMed:11163239, ECO:0000312|WormBase:Y47H9C.4a};
GN   ORFNames=Y47H9C.4 {ECO:0000312|WormBase:Y47H9C.4a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAG60061.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, IDENTIFICATION OF NPXY AND YXXL MOTIFS, PHOSPHORYLATION
RP   AT TYR-1019, AND MUTAGENESIS OF PRO-124; CYS-136; CYS-330; CYS-448;
RP   CYS-501; CYS-803; ASN-962; TYR-965 AND TYR-1019.
RC   TISSUE=Embryo {ECO:0000269|PubMed:11163239};
RX   PubMed=11163239; DOI=10.1016/s0092-8674(01)00190-8;
RA   Zhou Z., Hartwieg E., Horvitz H.R.;
RT   "CED-1 is a transmembrane receptor that mediates cell corpse engulfment in
RT   C. elegans.";
RL   Cell 104:43-56(2001).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAA21739.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=6857247; DOI=10.1126/science.6857247;
RA   Hedgecock E.M., Sulston J.E., Thomson J.N.;
RT   "Mutations affecting programmed cell deaths in the nematode Caenorhabditis
RT   elegans.";
RL   Science 220:1277-1279(1983).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=1936965; DOI=10.1093/genetics/129.1.79;
RA   Ellis R.E., Jacobson D.M., Horvitz H.R.;
RT   "Genes required for the engulfment of cell corpses during programmed cell
RT   death in Caenorhabditis elegans.";
RL   Genetics 129:79-94(1991).
RN   [5] {ECO:0000305}
RP   INTERACTION WITH CED-6.
RX   PubMed=11729193; DOI=10.1074/jbc.m109336200;
RA   Su H.P., Nakada-Tsukui K., Tosello-Trampont A.-C., Li Y., Bu G.,
RA   Henson P.M., Ravichandran K.S.;
RT   "Interaction of CED-6/GULP, an adapter protein involved in engulfment of
RT   apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-
RT   related protein (LRP).";
RL   J. Biol. Chem. 277:11772-11779(2002).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF 375-GLN--THR-1111.
RX   PubMed=12944970; DOI=10.1038/nature01920;
RA   Bloss T.A., Witze E.S., Rothman J.H.;
RT   "Suppression of CED-3-independent apoptosis by mitochondrial betaNAC in
RT   Caenorhabditis elegans.";
RL   Nature 424:1066-1071(2003).
RN   [7] {ECO:0000305}
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-333, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=12754521; DOI=10.1038/nbt829;
RA   Kaji H., Saito H., Yamauchi Y., Shinkawa T., Taoka M., Hirabayashi J.,
RA   Kasai K., Takahashi N., Isobe T.;
RT   "Lectin affinity capture, isotope-coded tagging and mass spectrometry to
RT   identify N-linked glycoproteins.";
RL   Nat. Biotechnol. 21:667-672(2003).
RN   [8] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=15744306; DOI=10.1038/nature03263;
RA   Kinchen J.M., Cabello J., Klingele D., Wong K., Feichtinger R.,
RA   Schnabel H., Schnabel R., Hengartner M.O.;
RT   "Two pathways converge at CED-10 to mediate actin rearrangement and corpse
RT   removal in C. elegans.";
RL   Nature 434:93-99(2005).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16740477; DOI=10.1016/j.devcel.2006.04.007;
RA   Yu X., Odera S., Chuang C.H., Lu N., Zhou Z.;
RT   "C. elegans Dynamin mediates the signaling of phagocytic receptor CED-1 for
RT   the engulfment and degradation of apoptotic cells.";
RL   Dev. Cell 10:743-757(2006).
RN   [10] {ECO:0000305}
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-66 AND ASN-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.m600392-mcp200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18606143; DOI=10.1016/j.devcel.2008.05.006;
RA   Haskins K.A., Russell J.F., Gaddis N., Dressman H.K., Aballay A.;
RT   "Unfolded protein response genes regulated by CED-1 are required for
RT   Caenorhabditis elegans innate immunity.";
RL   Dev. Cell 15:87-97(2008).
RN   [12] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18351800; DOI=10.1371/journal.pbio.0060061;
RA   Yu X., Lu N., Zhou Z.;
RT   "Phagocytic receptor CED-1 initiates a signaling pathway for degrading
RT   engulfed apoptotic cells.";
RL   PLoS Biol. 6:E61-E61(2008).
RN   [13]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26598553; DOI=10.1242/jcs.174201;
RA   Min H., Shim Y.H., Kawasaki I.;
RT   "Loss of PGL-1 and PGL-3, members of a family of constitutive germ-granule
RT   components, promotes germline apoptosis in C. elegans.";
RL   J. Cell Sci. 129:341-353(2016).
RN   [14]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27650246; DOI=10.1038/srep33884;
RA   Al-Amin M., Min H., Shim Y.H., Kawasaki I.;
RT   "Somatically expressed germ-granule components, PGL-1 and PGL-3, repress
RT   programmed cell death in C. elegans.";
RL   Sci. Rep. 6:33884-33884(2016).
CC   -!- FUNCTION: Involved in programmed cell death, also called apoptosis, in
CC       both somatic and germ cells (PubMed:11163239, PubMed:6857247,
CC       PubMed:1936965, PubMed:15744306, PubMed:16740477, PubMed:18351800,
CC       PubMed:26598553, PubMed:27650246, PubMed:12944970). Acts by recruiting
CC       ced-6 to phagosomes which enables actin-dependent cytoskeletal
CC       reorganization and subsequent engulfment of the apoptotic cell corpse
CC       (PubMed:15744306). Has a role in the association of ppk-3 and rab-7
CC       with the phagosomal surface which is necessary for the incorporation of
CC       lysosomes to phagosomes during phagosome maturation (PubMed:16740477,
CC       PubMed:18351800). Activates the expression of unfolded protein response
CC       genes, which are involved in the immune response to live bacteria
CC       (PubMed:18606143). {ECO:0000269|PubMed:11163239,
CC       ECO:0000269|PubMed:12944970, ECO:0000269|PubMed:15744306,
CC       ECO:0000269|PubMed:16740477, ECO:0000269|PubMed:18351800,
CC       ECO:0000269|PubMed:18606143, ECO:0000269|PubMed:1936965,
CC       ECO:0000269|PubMed:26598553, ECO:0000269|PubMed:27650246,
CC       ECO:0000269|PubMed:6857247}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with ced-6 (via PTB domain).
CC       {ECO:0000269|PubMed:11729193}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11163239};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:11163239}.
CC       Cytoplasmic vesicle, phagosome membrane {ECO:0000269|PubMed:11163239};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:11163239}.
CC       Note=Colocalizes with ced-6 and actin halos around early apoptotic
CC       cells. Temporally colocalizes with dyn-1 during engulfment of cell
CC       corpses. {ECO:0000255, ECO:0000269|PubMed:11163239}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=a {ECO:0000312|WormBase:Y47H9C.4a};
CC         IsoId=Q9XWD6-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:Y47H9C.4b};
CC         IsoId=Q9XWD6-2; Sequence=VSP_053136;
CC       Name=c {ECO:0000312|WormBase:Y47H9C.4c};
CC         IsoId=Q9XWD6-3; Sequence=VSP_053135, VSP_053137;
CC       Name=d {ECO:0000312|WormBase:Y47H9C.4d};
CC         IsoId=Q9XWD6-4; Sequence=VSP_053133, VSP_053134;
CC   -!- TISSUE SPECIFICITY: Expressed in engulfing cells and syncytium
CC       hypodermal cells. Ced-7 is necessary for clustering around cell corpses
CC       prior to engulfment. {ECO:0000269|PubMed:11163239}.
CC   -!- DOMAIN: NPXY motif thought to be involved in signal transduction that
CC       activates the cell corpse internalization process.
CC       {ECO:0000269|PubMed:11163239}.
CC   -!- PTM: Phosphorylation of Tyr-1019, within the YXXL motif, is thought to
CC       initiate phagosomal formation. {ECO:0000269|PubMed:11163239}.
CC   -!- DISRUPTION PHENOTYPE: Accumulation of cell corpses (PubMed:26598553).
CC       Appears immunocompromised resulting in susceptibility to bacterial
CC       infection (PubMed:6857247, PubMed:1936965, PubMed:18606143). Reduced or
CC       lack of association of ppk-3 and rab-7 with the phagosomal surface
CC       (PubMed:18351800). Defective in the recruitment of lysosomes to
CC       phagosomes (PubMed:16740477). Double knockout with the P-granule
CC       component pgl-1 results in an increased number of cell corpses in the
CC       gonad as compared to the ced-1 single mutant (PubMed:26598553).
CC       Conversely, double knockout with pgl-1 or pgl-3 results in reduced
CC       somatic cell apoptosis (PubMed:27650246). Double knockout with the
CC       synthetic multivulva class B protein hpl-2 results in reduced somatic
CC       cell apoptosis at 25 degrees Celsius (PubMed:27650246). Triple knockout
CC       with hpl-2 and pgl-1 partially recovers the reduced somatic cell
CC       apoptotic cell defect in the ced-1 and hpl-2 double knockout
CC       (PubMed:27650246). Triple knockout with hpl-2 and pgl-1 and knockdown
CC       with either ced-3 or ced-4 reduces the somatic cell apoptosis defect in
CC       the ced-1, hpl-2 and pgl-1 triple knockout (PubMed:27650246). Double
CC       knockout with hpl-2 and knockdown with either pgl-1, pgl-3, glh-1 or
CC       glh-4 RNAi rescues the reduced somatic cell apoptotic cell defect in
CC       the ced-1 and hpl-2 double knockout (PubMed:27650246). Knockout with
CC       RNAi-mediated knockdown of synthetic multivulva class B proteins lin-9,
CC       lin-35, lin-37 or lin-54 results in reduced somatic cell apoptosis
CC       (PubMed:27650246). {ECO:0000269|PubMed:16740477,
CC       ECO:0000269|PubMed:18351800, ECO:0000269|PubMed:18606143,
CC       ECO:0000269|PubMed:1936965, ECO:0000269|PubMed:26598553,
CC       ECO:0000269|PubMed:27650246, ECO:0000269|PubMed:6857247}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF332568; AAG60061.1; -; mRNA.
DR   EMBL; BX284601; CAA21739.1; -; Genomic_DNA.
DR   EMBL; BX284601; CAD27614.1; -; Genomic_DNA.
DR   EMBL; BX284601; CAD27615.1; -; Genomic_DNA.
DR   EMBL; BX284601; CAL44979.1; -; Genomic_DNA.
DR   PIR; T26972; T26972.
DR   RefSeq; NP_001021772.1; NM_001026601.3. [Q9XWD6-2]
DR   RefSeq; NP_001021773.1; NM_001026602.3.
DR   RefSeq; NP_001076621.1; NM_001083152.2. [Q9XWD6-4]
DR   RefSeq; NP_740922.1; NM_170927.4. [Q9XWD6-1]
DR   AlphaFoldDB; Q9XWD6; -.
DR   SMR; Q9XWD6; -.
DR   BioGRID; 38467; 6.
DR   ELM; Q9XWD6; -.
DR   IntAct; Q9XWD6; 1.
DR   MINT; Q9XWD6; -.
DR   STRING; 6239.Y47H9C.4a; -.
DR   iPTMnet; Q9XWD6; -.
DR   EPD; Q9XWD6; -.
DR   PaxDb; Q9XWD6; -.
DR   PeptideAtlas; Q9XWD6; -.
DR   EnsemblMetazoa; Y47H9C.4a.1; Y47H9C.4a.1; WBGene00000415. [Q9XWD6-1]
DR   EnsemblMetazoa; Y47H9C.4b.1; Y47H9C.4b.1; WBGene00000415. [Q9XWD6-2]
DR   EnsemblMetazoa; Y47H9C.4c.1; Y47H9C.4c.1; WBGene00000415. [Q9XWD6-3]
DR   EnsemblMetazoa; Y47H9C.4d.1; Y47H9C.4d.1; WBGene00000415. [Q9XWD6-4]
DR   GeneID; 173064; -.
DR   KEGG; cel:CELE_Y47H9C.4; -.
DR   UCSC; Y47H9C.4a; c. elegans.
DR   CTD; 173064; -.
DR   WormBase; Y47H9C.4a; CE20264; WBGene00000415; ced-1. [Q9XWD6-1]
DR   WormBase; Y47H9C.4b; CE30361; WBGene00000415; ced-1. [Q9XWD6-2]
DR   WormBase; Y47H9C.4c; CE30362; WBGene00000415; ced-1. [Q9XWD6-3]
DR   WormBase; Y47H9C.4d; CE40433; WBGene00000415; ced-1. [Q9XWD6-4]
DR   eggNOG; KOG1218; Eukaryota.
DR   GeneTree; ENSGT00940000167451; -.
DR   InParanoid; Q9XWD6; -.
DR   OMA; CSKPCPQ; -.
DR   OrthoDB; 561378at2759; -.
DR   PhylomeDB; Q9XWD6; -.
DR   Reactome; R-CEL-114608; Platelet degranulation.
DR   Reactome; R-CEL-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus.
DR   Reactome; R-CEL-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins.
DR   Reactome; R-CEL-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-CEL-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-CEL-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:Q9XWD6; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00000415; Expressed in pharyngeal muscle cell (C elegans) and 4 other tissues.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0001891; C:phagocytic cup; IDA:WormBase.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0031260; C:pseudopodium membrane; IDA:WormBase.
DR   GO; GO:0005044; F:scavenger receptor activity; IPI:WormBase.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:1902742; P:apoptotic process involved in development; IMP:UniProtKB.
DR   GO; GO:0034620; P:cellular response to unfolded protein; IDA:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:0043652; P:engulfment of apoptotic cell; IDA:UniProtKB.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IGI:UniProtKB.
DR   GO; GO:0045184; P:establishment of protein localization; IDA:UniProtKB.
DR   GO; GO:0070986; P:left/right axis specification; IGI:UniProtKB.
DR   GO; GO:0001845; P:phagolysosome assembly; IMP:UniProtKB.
DR   GO; GO:1904747; P:positive regulation of apoptotic process involved in development; IMP:UniProtKB.
DR   GO; GO:1903356; P:positive regulation of distal tip cell migration; IMP:UniProtKB.
DR   GO; GO:1901076; P:positive regulation of engulfment of apoptotic cell; IMP:UniProtKB.
DR   GO; GO:0012501; P:programmed cell death; IMP:UniProtKB.
DR   GO; GO:0043654; P:recognition of apoptotic cell; IDA:WormBase.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR011489; EMI_domain.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR002049; LE_dom.
DR   Pfam; PF00053; Laminin_EGF; 5.
DR   SMART; SM00181; EGF; 17.
DR   SMART; SM00180; EGF_Lam; 16.
DR   SMART; SM00261; FU; 5.
DR   PROSITE; PS00022; EGF_1; 15.
DR   PROSITE; PS01186; EGF_2; 11.
DR   PROSITE; PS50026; EGF_3; 6.
DR   PROSITE; PS51041; EMI; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Cell membrane; Cytoplasmic vesicle;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..1111
FT                   /note="Cell death abnormality protein 1"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000379932"
FT   TOPO_DOM        19..910
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        911..931
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        932..1111
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          41..113
FT                   /note="EMI"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00384"
FT   DOMAIN          118..148
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          156..191
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          199..233
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          241..276
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          421..458
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          629..680
FT                   /note="FU"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          681..716
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          940..993
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1006..1111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           962..965
FT                   /note="NPXY"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1019..1022
FT                   /note="YXXL"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        959..989
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1026..1049
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1071..1111
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1019
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17761667"
FT   CARBOHYD        333
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754521,
FT                   ECO:0000269|PubMed:17761667"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        456
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        45..106
FT                   /evidence="ECO:0000255"
FT   DISULFID        71..80
FT                   /evidence="ECO:0000255"
FT   DISULFID        105..117
FT                   /evidence="ECO:0000255"
FT   DISULFID        121..130
FT                   /evidence="ECO:0000255"
FT   DISULFID        125..136
FT                   /evidence="ECO:0000255"
FT   DISULFID        138..147
FT                   /evidence="ECO:0000255"
FT   DISULFID        160..172
FT                   /evidence="ECO:0000255"
FT   DISULFID        166..179
FT                   /evidence="ECO:0000255"
FT   DISULFID        181..190
FT                   /evidence="ECO:0000255"
FT   DISULFID        203..215
FT                   /evidence="ECO:0000255"
FT   DISULFID        209..221
FT                   /evidence="ECO:0000255"
FT   DISULFID        223..232
FT                   /evidence="ECO:0000255"
FT   DISULFID        245..257
FT                   /evidence="ECO:0000255"
FT   DISULFID        251..264
FT                   /evidence="ECO:0000255"
FT   DISULFID        266..275
FT                   /evidence="ECO:0000255"
FT   DISULFID        425..439
FT                   /evidence="ECO:0000255"
FT   DISULFID        431..446
FT                   /evidence="ECO:0000255"
FT   DISULFID        448..457
FT                   /evidence="ECO:0000255"
FT   DISULFID        685..697
FT                   /evidence="ECO:0000255"
FT   DISULFID        691..704
FT                   /evidence="ECO:0000255"
FT   DISULFID        706..715
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..49
FT                   /note="MRLILLVLLATWQVVVDTRAPTFPDKLTQQLQQQGTTEPQGDHVCTVKT ->
FT                   MCVPRDIGSRVKTHTPTSHHRTPSPRTLRTKNVLRTICTPKFEFSYIFF (in
FT                   isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053133"
FT   VAR_SEQ         50..1111
FT                   /note="Missing (in isoform d)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053134"
FT   VAR_SEQ         1017..1082
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053135"
FT   VAR_SEQ         1042..1082
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053136"
FT   VAR_SEQ         1083
FT                   /note="E -> K (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053137"
FT   MUTAGEN         124
FT                   /note="P->L: In n1995; increase in corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         136
FT                   /note="C->Y: In n2091; increase in corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         330
FT                   /note="C->Y: In n2089; increase in corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         375..1111
FT                   /note="Missing: In e1735; defective clearance of apoptotic
FT                   cell corpses in embryos."
FT                   /evidence="ECO:0000269|PubMed:12944970"
FT   MUTAGEN         448
FT                   /note="C->Y: In e1797, n2000, and n2092; increase in
FT                   corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         501
FT                   /note="C->Y: In n1951; increase in corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         803
FT                   /note="C->Y: In e1801; increase in corpses in L1 head."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         962
FT                   /note="N->A: 85% loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         965
FT                   /note="Y->A: 71% loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11163239"
FT   MUTAGEN         1019
FT                   /note="Y->A: 54% loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11163239"
SQ   SEQUENCE   1111 AA;  118804 MW;  A39F374C008F9874 CRC64;
     MRLILLVLLA TWQVVVDTRA PTFPDKLTQQ LQQQGTTEPQ GDHVCTVKTI VDDYELKKVI
     HTVVYNDTEQ CLNPLTGFQC TVEKRGQKAS YQRQLVKKEK YVKQCCDGYY QTKDHFCLPD
     CNPPCKKGKC IEPGKCECDP GYGGKYCASS CSVGTWGLGC SKSCDCENGA NCDPELGTCI
     CTSGFQGERC EKPCPDNKWG PNCVKSCPCQ NGGKCNKEGK CVCSDGWGGE FCLNKCEEGK
     FGAECKFECN CQNGATCDNT NGKCICKSGY HGALCENECS VGFFGSGCTQ KCDCLNNQNC
     DSSSGECKCI GWTGKHCDIG CSRGRFGLQC KQNCTCPGLE FSDSNASCDA KTGQCQCESG
     YKGPKCDERK CDAEQYGADC SKTCTCVREN TLMCAPNTGF CRCKPGFYGD NCELACSKDS
     YGPNCEKQAM CDWNHASECN PETGSCVCKP GRTGKNCSEP CPLDFYGPNC AHQCQCNQRG
     VGCDGADGKC QCDRGWTGHR CEHHCPADTF GANCEKRCKC PKGIGCDPIT GECTCPAGLQ
     GANCDIGCPE GSYGPGCKLH CKCVNGKCDK ETGECTCQPG FFGSDCSTTC SKGKYGESCE
     LSCPCSDASC SKQTGKCLCP LGTKGVSCDQ KCDPNTFGFL CQETVTPSPC ASTDPKNGVC
     LSCPPGSSGI HCEHNCPAGS YGDGCQQVCS CADGHGCDPT TGECICEPGY HGKTCSEKCP
     DGKYGYGCAL DCPKCASGST CDHINGLCIC PAGLEGALCT RPCSAGFWGN GCRQVCRCTS
     EYKQCNAQTG ECSCPAGFQG DRCDKPCEDG YYGPDCIKKC KCQGTATSSC NRVSGACHCH
     PGFTGEFCHA LCPESTFGLK CSKECPKDGC GDGYECDAAI GCCHVDQMSC GKAKQEFEAL
     NGAGRSTGLT WFFVLLIVAL CGGLGLIALF YRNKYQKEKD PDMPTVSFHK APNNDEGREF
     QNPLYSRQSV FPDSDAFSSE NNGNHQGGPP NGLLTLEEEE LENKKIHGRS AAGRGNNDYA
     SLDEVAGEGS SSSASASASR RGLNSSEQSR RPLLEEHDEE EFDEPHENSI SPAHAVTTSN
     HNENPYADIS SPDPVTQNSA NKKRAQDNLY T
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024